Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: BASF AS, P.O Box 420, 1327 Lysaker, Norway
Endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response:
Initial treatment two capsules daily. If adequate response is not obtained, the dose may be increased to four capsules daily.
The capsules may be taken with food to avoid gastrointestinal disturbances.
There is limited clinical data regarding the use of Omacor in elderly patients over 70 years of age and patients with renal impairment (see section 4.4). There is no information regarding the use of Omacor in children and adolescents or in patients with hepatic impairment (see section 4.4).
There are no special recommendations.
Treatment should be symptomatic.
3 years.
Do not store above 25ºC. Do not freeze.
White high density polyethylene (HDPE) bottle:
Not all pack sizes may be marketed.
Any unused product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
